RND2
Rho-related GTP-binding protein RhoN
Also known as: ARHN, Rho7, RhoN, RND2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P52198
- Gene
- RND2
- Ensembl
- ENSG00000108830
- Chromosome
- 17
- Canonical length
- 227 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a member of the Rho GTPase family, whose members play a key role in the regulation of actin cytoskeleton organization in response to extracellular growth factors. This particular family member has been implicated in the regulation of neuronal morphology and endosomal trafficking. The gene localizes to chromosome 17 and is the centromeric neighbor of the breast-ovarian cancer susceptibility gene BRCA1. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
227 residues, UniProt reviewed canonical sequence.
>P52198|RND2
1 MEGQSGRCKI VVVGDAECGK TALLQVFAKD AYPGSYVPTV FENYTASFEI DKRRIELNMW
61 DTSGSSYYDN VRPLAYPDSD AVLICFDISR PETLDSVLKK WQGETQEFCP NAKVVLVGCK
121 LDMRTDLATL RELSKQRLIP VTHEQGTVLA KQVGAVSYVE CSSRSSERSV RDVFHVATVA
181 SLGRGHRQLR RTDSRRGMQR SAQLSGRPDR GNEGEIHKDR AKSCNLMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RND2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 95 nTPM
Expression across tissuesHPA
Tissue
- midbrain: 95 nTPM
- spinal cord: 91 nTPM
- hypothalamus: 72 nTPM
- basal ganglia: 43 nTPM
- testis: 36 nTPM
- amygdala: 28 nTPM
Single-cell type
- late spermatids: 1,019 nCPM
- early spermatids: 133 nCPM
- late primary spermatocytes: 108 nCPM
- oocytes: 28 nCPM
- other brain neurons: 22 nCPM
- oligodendrocyte progenitor cells: 20 nCPM
Immune cell
- basophil: 0.4 nTPM
- memory B-cell: 0.2 nTPM
- gdT-cell: 0.1 nTPM
- naive B-cell: 0.1 nTPM
- neutrophil: 0.1 nTPM
- NK-cell: 0.1 nTPM
Brain region
- medulla oblongata: 114 nTPM
- midbrain: 106 nTPM
- pons: 89 nTPM
- spinal cord: 81 nTPM
- hypothalamus: 80 nTPM
- cerebellum: 77 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.11
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.73
- DepMap mean gene effect
- -0.15
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin filament organization
- collateral sprouting
- positive regulation of collateral sprouting
- regulation of actin cytoskeleton organization
- signal transduction
- small GTPase-mediated signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Small GTPase
- Small GTPase Rho
- Small GTP-binding domain
- P-loop containing nucleoside triphosphate hydrolase
- Ras family
- Rho-related GTP-binding protein RhoN
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RND2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RND2 as an antibody target. Whether an autoantibody or antibody against RND2 could matter depends on whether native RND2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RND2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RND2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...